Notably, we found substantial connections between the expression of BIRC5, E2F1, SFN, and UBE2C and the pathological stage of HCC (Figure 9A), indicating their potential as indicators of tumor progression and severity. This evidence concerns the gene SFN and hepatocellular carcinoma.